Cargando…

Changes in oligodendroglial subpopulations in Parkinson’s disease

Parkinson’s disease (PD) is characterized by a selective loss of dopaminergic neurons. While most research on PD conducted to date has focused on neurons and, to a certain extent, glia, few studies have investigated changes in oligodendroglia. Here, we investigated the heterogeneity of oligodendrocy...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Eun-Jin, Pérez-Acuña, Dayana, Rhee, Ka Hyun, Lee, Seung-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10500805/
https://www.ncbi.nlm.nih.gov/pubmed/37710343
http://dx.doi.org/10.1186/s13041-023-01055-5
Descripción
Sumario:Parkinson’s disease (PD) is characterized by a selective loss of dopaminergic neurons. While most research on PD conducted to date has focused on neurons and, to a certain extent, glia, few studies have investigated changes in oligodendroglia. Here, we investigated the heterogeneity of oligodendrocytes from PD patients compared with those of control cases by analyzing single-nuclei transcriptomes. These analyses revealed the presence of distinct oligodendrocyte populations in PD patients indicative of corresponding variations in molecular features, notably including activation of inflammatory responses, response to protein folding stress, and myelination abnormalities. We confirmed myelination abnormalities in an α-synuclein preformed fibril-injection mouse model of PD. These results suggest that oligodendrocytes acquire disease-associated phenotypes in PD and may contribute to the accompanying neurodegeneration. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13041-023-01055-5.